Last reviewed · How we verify

NCT04643015

New Ways of Doing Magnetic Resonance Imaging in Children and Adults

Active, enrolled Last updated 3 September 2025
What this trial tests

trial testing MRI in Pediatric Disorder in 21 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
18 November 2020
Primary endpoint
18 November 2026
18 November 2026

Quick facts

Lead sponsorMemorial Sloan Kettering Cancer Center
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment21
Start date18 November 2020
Primary completion18 November 2026
Estimated completion18 November 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Memorial Sloan Kettering Cancer Center — full company profile →

Who can join

Eligibility, any sex, with Pediatric Disorder or Adult Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being done to see how we can prevent problems caused by movement during the MRI scan. Different ways of doing the scan (techniques) will be tested to see if they are practical and can prevent problems related to motion. For example, changes in the timing of the magnetic field and the radio waves will be examined, and at changes in the way a computer is used to process the images. The new techniques will be compared with the techniques that are usually used.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

Other recruiting trials for Pediatric Disorder

Currently open trials in the same condition.

Other Memorial Sloan Kettering Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04643015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing